Early diagnosis of amoebic dysentery is challenging due to its diverse manifestations and potential for recurrence, with no known treatment guaranteeing a cure.

Amoebiasis: Some Difficulties of Diagnosis*

Amoebiasis is an infectious disease caused by Entamoeba histolytica, with common symptoms including cramping, abdominal pain, diarrhea, and weight loss.

Amoebiasis: An Infectious Disease Caused by Entamoeba histolytica

Thoracic amoebiasis presents as a febrile illness with cough, chest pain, and point tenderness in the intercostal space or right upper quadrant of the abdomen, and should be considered in the evaluation of obscure, right-sided respiratory symptoms in endemic areas.

Intrathoracic manifestations of amoebiasis.

Steroid treatment may exacerbate liver amoebiasis, so patients with tropics-related amoebiasis should be tested for amoebiasis before receiving corticosteroids.

Corticosteroids and liver amoebiasis.

Interdisciplinary collaboration and persistent efforts are crucial for accurate diagnosis of extraintestinal amoebiasis, which is often misdiagnosed due to its declining incidence and atypical symptoms.

The Challenging Path to Diagnosing Extraintestinal Amoebiasis: A Case Report of an HIV-Infected Patient

Non-dysenteric intestinal amoebiasis is extremely rare, and most chronic abdominal pain and frequent bowel disturbances are likely to be caused by irritable bowel syndrome (IBS).

Does non-dysenteric intestinal amoebiasis exist?

Amoebiasis is a surprisingly common but difficult-to-diagnose disease in the Far East, with a significant risk to Europeans due to its reluctance to seek advice and its potential for spreading through cyst-passers.

The Diagnosis of Amoebiasis

Intestinal amoebiasis remains a health problem in developing countries, with a need for accessible diagnostic methods and effective vaccines to protect against this parasite.

Intestinal amoebiasis: 160 years of its first detection and still remains as a health problem in developing countries.

Probiotics show promise as an alternative and effective treatment for amoebiasis patients, offering a promising alternative to potentially harmful medications like metronidazole.

Amoebiasis and probiotics: perspectives on complementary treatment

Intestinal amoebiasis and amoebic liver abscess are common in Brisbane, with diagnostic difficulties and metronidazole being effective and safe in cases of suspected but unproven amoebiasis.

Intestinal amoebiasis and amoebic liver abscess in Brisbane, 1956 to 1973. Clinical syndromes and the results of medical and surgical management.

Invasive intestinal amoebiasis should be considered as a differential diagnosis for adult IBD-like symptoms, even with suggestive endoscopic findings of Crohn's-like ulcers.

Multiple colonic and ileal perforations due to unsuspected intestinal amoebiasis-Case report and review.

The treatment of amoebiasis focuses on eradicating the parasite, Entamoeba histolytica, and preventing its recurrence.

Treatment of Amoebiasis

Sexual transmission of amoebiasis can occur in non-endemic areas, even in individuals who have never travelled abroad, and should be considered in cases of liver abscesses or chronic diarrhoea.

An underestimated sexually transmitted infection: amoebiasis

Primary pulmonary amoebiasis is a rare but important etiology to consider in the differential diagnosis of pulmonary abscesses, even when there are no gastrointestinal disturbances.

A Rare Case of Primary Pulmonary Amoebiasis without Gastrointestinal Involvement: A Case Report

Two genetically distinct species of Entamoeba histolytica, the pathogen and Entamoeba dispar, have revolutionized our understanding of amoebiasis epidemiology and diagnosis, with new models linking intestinal inflammation and hepatocyte programmed cell death to disease pathogenesis.

Amoebiasis

not marshal our forces to the same extent against amcebiasis, yet amoebiasis is the more serious disease. Each attack leaves the patient in poorer physical condition, and each attack renders cure less likely* We failed to appreciate the importance of this point; we were not sufficiently amoebic-conscious at the time when the patient first complained of diarrhoea, abdominal pain, or other symptom ; we did not put accurate diagnosis in the forefront at the first attack ; we were content to accept symptomatic recovery of the first attack as cure of the amoebiasis. We, in India at least, reaped the tares. It was poor comfort to know that our enemy was having equally discouraging results. From captured documents we ascertained that

Amoebiasis.

Gal/GalNAc lectin plays a crucial role in amoebiasis vaccine development, regulating parasite adherence, pathogenicity, signaling, encystment, and host immune response.

Amoebiasis vaccine development: A snapshot on E. histolytica with emphasis on perspectives of Gal/GalNAc lectin.

Newer, more sensitive methods are needed for accurate and cost-effective laboratory diagnosis of amoebiasis in developing countries.

Update on laboratory diagnosis of amoebiasis

Amoebiasis is a worldwide disease caused by the motile trophozoite of Entamoeba histolytica, which lives in the large intestine and causes luminal amoebiasis, with no clinical signs or symptoms, and invasive amoebiasis,

The pathogenesis of amoebiasis.

Key hub genes (JUN, PTGS2, CCL2, and MNDA) and their associated miRNAs are primary targets for therapeutic methods and potential biomarkers in Amoebiasis infection.

Entamoeba histolytica HM-1: IMSS gene expression profiling identifies key hub genes, potential biomarkers, and pathways in Amoebiasis infection: a systematic network meta-analysis

These studies suggest that the symptoms of amoebiasis include cramping, abdominal pain, diarrhea, weight loss, and in some cases, febrile illness with cough and chest pain.